BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 2434415)

  • 1. Allogeneic lymphocyte cytotoxicity (ALC) in rats: establishment of an in vitro assay, and direct evidence that cells with natural killer (NK) activity are involved in ALC.
    Rolstad B; Fossum S
    Immunology; 1987 Feb; 60(2):151-7. PubMed ID: 2434415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The rapid rejection of allogeneic lymphocytes by a non-adaptive, cell-mediated mechanism (NK activity).
    Rolstad B; Fossum S; Bazin H; Kimber I; Marshall J; Sparshott SM; Ford WL
    Immunology; 1985 Jan; 54(1):127-38. PubMed ID: 3972430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
    Bonavida B; Lebow LT; Bradley TP
    J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allospecific recognition of hemic cells in vitro by natural killer cells from athymic rats: evidence that allodeterminants coded for by single major histocompatibility complex haplotypes are recognized.
    Vaage JT; Dissen E; Ager A; Fossum S; Rolstad B
    Eur J Immunol; 1991 Sep; 21(9):2167-75. PubMed ID: 1716212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of membrane markers on rat cytotoxic cells.
    Cantrell DA; Robins RA; Baldwin RW
    Immunology; 1983 May; 49(1):139-46. PubMed ID: 6220963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer cell activity in the rat. Analysis of effector cell morphology and effects of interferon on natural killer cell function in the athymic (nude) rat.
    Reynolds CW; Timonen TT; Holden HT; Hansen CT; Herberman RB
    Eur J Immunol; 1982 Jul; 12(7):577-82. PubMed ID: 6180907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells.
    Vujanovic NL; Herberman RB; Olszowy MW; Cramer DV; Salup RR; Reynolds CW; Hiserodt JC
    Cancer Res; 1988 Feb; 48(4):884-90. PubMed ID: 3257412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies against leucoagglutinin-reactive human T lymphocyte surface components. Two antibodies which inhibit cell-mediated cytotoxicity at a post-binding stage.
    Vargas-Cortes M; Hammarström ML; Hammarström S; Hellström U; Perlmann P
    Eur J Immunol; 1986 Jul; 16(7):795-801. PubMed ID: 3522246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice.
    Brunda MJ; Taramelli D; Holden HT; Varesio L
    J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-2- and mitogen-activated NK-like killer cells from highly purified human peripheral blood T cell (CD3+ N901-) cultures.
    Atzpodien J; Wisniewski D; Gulati S; Welte K; Knowles R; Clarkson B
    Nat Immun Cell Growth Regul; 1987; 6(3):129-40. PubMed ID: 3114621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells.
    Burns GF; Triglia T; Werkmeister JA
    J Immunol; 1984 Sep; 133(3):1656-63. PubMed ID: 6611374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
    Colotta F; Peri G; Villa A; Mantovani A
    J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF).
    Wright SC; Bonavida B
    J Immunol; 1983 Jun; 130(6):2960-4. PubMed ID: 6189908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphokine-activated killer cells in rats. IV. Developmental relationships among large agranular lymphocytes, large granular lymphocytes, and lymphokine-activated killer cells.
    Maghazachi AA; Vujanovic NL; Herberman RB; Hiserodt JC
    J Immunol; 1988 Apr; 140(8):2846-52. PubMed ID: 3258622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotype of cytotoxic effector cells infiltrating a transplanted, chemically induced rat sarcoma.
    Ferry BL; Flannery GR; Robins RA; Lawry J; Baldwin RW
    Immunology; 1984 Oct; 53(2):243-50. PubMed ID: 6490084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous alloreactivity of natural killer (NK) and lymphokine-activated killer (LAK) cells from athymic rats against normal haemic cells. NK cells stimulate syngeneic but inhibit allogeneic haemopoiesis.
    Rolstad B; Benestad HB
    Immunology; 1991 Sep; 74(1):86-93. PubMed ID: 1937576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
    Kalland T; Belfrage H; Bhiladvala P; Hedlund G
    J Immunol; 1987 Jun; 138(11):3640-5. PubMed ID: 3495566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for an early calcium-independent event in the activation of the human natural killer cell cytolytic mechanism.
    Brahmi Z; Bray RA; Abrams SI
    J Immunol; 1985 Dec; 135(6):4108-13. PubMed ID: 3864859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
    J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.